FerringPharmaceuticalstoExploreStrategicOptionsforRebyota
===2025/10/30 15:24:58===
afety Information
You should not receive Rebyota if you have a history of a severe allergic reaction (e.g., anaphylaxis) to Rebyota or any of its components.
You should report to your doctor any infection you think you may have acquired after administration.
Rebyota may contain food allergens.
Most common side effects may include stomach pain (8.9%), diarrhoea (7.2%), bloating (3.9%), gas (3.3%), and nausea (3.3%).
Rebyota has not been studied in patients below 18 years of age.
Clinical studies did not determine if adults 65 years of age and older responded differently than younger adults.
You are encouraged to report negative side effects of prescription drugs to FDA. Visitwww.FDA.gov/medwatchor call 1-800-332-1088.
Please click to see the fullPrescribing Information.
Contacts
For more information, please contact:
United States and Canada enquiries
Patrick Gorman
Senior Director,
=*=*=*=*=*=
当前为第4/5页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页